| RS2134823666 |
SORL1
|
Health Risk |
Pathogenic |
— |
| RS2134830912 |
MRE11
|
Health Risk |
Pathogenic |
— |
| RS2134830919 |
NPAT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2134831001 |
MRE11
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia-like disorder, Ataxia-telangiectasia-like disorder |
| RS2134834493 |
NPAT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2134836650 |
BBS1
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, BBS1-related disorder |
| RS2134836723 |
BBS1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2134836882 |
BBS1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2134837160 |
BBS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS2134838763 |
MNX1
|
Health Risk |
Pathogenic |
— |
| RS2134838779 |
MNX1
|
Health Risk |
Likely pathogenic |
Currarino triad, Currarino triad |
| RS2134838783 |
MNX1
|
Health Risk |
Pathogenic |
Currarino triad, Currarino triad |
| RS2134840114 |
MNX1
|
Health Risk |
Likely pathogenic |
— |
| RS2134840169 |
MNX1
|
Health Risk |
Pathogenic |
— |
| RS2134840569 |
MRE11
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia-like disorder, Ataxia-telangiectasia-like disorder 1 |
| RS2134841394 |
BBS1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2134842358 |
COL13A1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 19, Congenital myasthenic syndrome 19 |
| RS2134845306 |
FERMT3
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 3, Leukocyte adhesion deficiency 3 |
| RS2134845840 |
MNX1
|
Health Risk |
Pathogenic |
— |
| RS2134846034 |
MNX1
|
Health Risk |
Pathogenic |
— |
| RS2134846165 |
MNX1
|
Health Risk |
Pathogenic |
Currarino triad, Currarino triad |
| RS2134846330 |
MNX1
|
Health Risk |
Pathogenic |
Currarino triad, Currarino triad |
| RS2134846391 |
MNX1
|
Health Risk |
Pathogenic |
— |
| RS2134847685 |
MNX1
|
Health Risk |
Pathogenic |
— |
| RS2134854631 |
HMBS
|
Health Risk |
Likely pathogenic |
— |
| RS2134854656 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2134854665 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2134856747 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2134856824 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2134858145 |
SORL1
|
Health Risk |
risk factor |
Alzheimer disease 9, Alzheimer disease 9 |
| RS2134859037 |
HMBS
|
Health Risk |
Likely pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS2134859316 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS2134862487 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2134862558 |
HMBS
|
Health Risk |
Likely pathogenic |
— |
| RS2134862738 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2134865264 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2134865826 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2134871639 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2134872053 |
HMBS
|
Health Risk |
Likely pathogenic |
— |
| RS2134876482 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2134876594 |
HMBS
|
Health Risk |
Pathogenic/Likely pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS2134878857 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2134878870 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2134880586 |
FERMT3
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 3, Leukocyte adhesion deficiency 3 |
| RS2134882159 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2134883951 |
HMBS
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2134884322 |
HMBS
|
Health Risk |
Pathogenic |
Hepatocellular carcinoma, Hepatocellular carcinoma |
| RS2134885195 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2134885452 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2134885529 |
DYNC2H1
|
Health Risk |
Pathogenic |
Asphyxiating thoracic dystrophy 3, Asphyxiating thoracic dystrophy 3 |
| RS2134885669 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2134885779 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS2134885911 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2134888290 |
PGM2L1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, dysmorphic facies |
| RS2134892263 |
SDHAF2
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS2134892271 |
SDHAF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS2134892531 |
SDHAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS2134892557 |
SDHAF2
|
Health Risk |
Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS2134892844 |
SDHAF2
|
Health Risk |
Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 2, Pheochromocytoma/paraganglioma syndrome 2 |
| RS2134893308 |
SORL1
|
Health Risk |
Pathogenic |
— |
| RS2134896978 |
DYNC2H1
|
Health Risk |
Pathogenic |
Asphyxiating thoracic dystrophy 3, Asphyxiating thoracic dystrophy 3 |
| RS2134898234 |
DPAGT1
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 13, Congenital myasthenic syndrome 13 |
| RS2134901573 |
DPAGT1
|
Health Risk |
Pathogenic |
DPAGT1-congenital disorder of glycosylation, Congenital myasthenic syndrome 13 |
| RS2134901685 |
PCDH15
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2134903748 |
DPAGT1
|
Health Risk |
Likely pathogenic |
DPAGT1-congenital disorder of glycosylation, Congenital myasthenic syndrome 13 |
| RS2134903776 |
FERMT3
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 3, Leukocyte adhesion deficiency 3 |
| RS2134904455 |
PCDH15
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2134908680 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2134910617 |
DPAGT1
|
Health Risk |
Likely pathogenic |
DPAGT1-congenital disorder of glycosylation, Congenital myasthenic syndrome 13 |
| RS2134916397 |
DDB1
|
Health Risk |
Pathogenic |
White-Kernohan syndrome, White-Kernohan syndrome |
| RS2134919748 |
DPAGT1
|
Health Risk |
Pathogenic |
DPAGT1-congenital disorder of glycosylation, Congenital myasthenic syndrome 13 |
| RS2134921669 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group C |
| RS2134922671 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2134925431 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group C |
| RS2134934938 |
DDB1
|
Health Risk |
Likely pathogenic |
White-Kernohan syndrome, White-Kernohan syndrome |
| RS2134935097 |
DDB1
|
Health Risk |
Pathogenic |
White-Kernohan syndrome, White-Kernohan syndrome |
| RS2134935103 |
DDB1
|
Health Risk |
Conflicting classifications of pathogenicity |
White-Kernohan syndrome, White-Kernohan syndrome |
| RS2134949827 |
CTSF
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2134950483 |
CTSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Neurodevelopmental disorder |
| RS2134951897 |
CTSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2134954582 |
CTSF
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2134954887 |
CTSF
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 13, Neuronal ceroid lipofuscinosis 13 |
| RS2134963520 |
PGM2L1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, dysmorphic facies |
| RS2134965356 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2134965481 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2134967046 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2134967717 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2134968283 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS2134968489 |
EXT2
|
Health Risk |
Pathogenic |
— |
| RS2134968744 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2134969994 |
MRE11
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia-like disorder 1, Ataxia-telangiectasia-like disorder 1 |
| RS2134971478 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2134971524 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2134971964 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2134978631 |
IL10RA;LOC130006833
|
Health Risk |
Likely pathogenic |
Inflammatory bowel disease 28, Inflammatory bowel disease 28 |
| RS2134978784 |
DKK3
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2134979684 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Asphyxiating thoracic dystrophy 3, Asphyxiating thoracic dystrophy 3 |
| RS2134984550 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2134984829 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2134985142 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |